← All trials
NCT04328012
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Apr 6, 2020
- Primary completion
- Jan 1, 2021
- Completion date
- Apr 1, 2021
- First posted
- Mar 31, 2020
- Last posted
- Apr 8, 2020
- Enrollment
- 4000
- Arms / groups
- 4 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Bassett HealthcareLead sponsor
- Bassett HealthcareOverall official - principal investigator
- Bassett HealthcareReponsible party - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.